Controllable genome-modified plasmodium, recombinant expression vector and construction method and application of controllable genome-modified plasmodium and recombinant expression vector

An expression vector and gene expression technology, applied in the field of genetic engineering, can solve the problems of easy loss of episomes, failure of normal growth and development of worm strains, difficulty in mass production, screening and cloning of transgenic worms, etc.

Inactive Publication Date: 2016-03-02
GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Other studies have combined the Cre / loxP or Flp / FRT system with gene knockout to achieve gene conditional knockout, but this gene conditional knockout technology is limited to the use of specific or tissue-specific promoters, and this conditional knockout It is irreversible except in a specific period or in a specific tissue. Therefore, for most of the malaria parasites that are haploid in the growth period, there are still important gene deletions that cause the parasites to die or be severely damaged, so that transgenic parasites cannot be screened and cloning problems, and genes that are important for each growth stage of Plasmodium are more difficult to study in this way
The gene-induced expression method used in animal cells often uses some special promoters, which can be induced under certain physical and chemical conditions, such as the heat shock protein promoter can be induced at high temperature, glucocorticoid and heavy metal response Promoters, etc. These gene expression induction methods have the following defects: poor specificity of induced expression, expression leakage when the system is closed, and the toxicity of the inducer itself can cause damage to cells, etc.
In 2005, the tet-off system constructed by Meissner et al. regulated the expression of the green fluorescent protein (GFP) gene in human Plasmodium falciparum (Proc.Natl.Acad.Sci.USA.2005,102(8):2980-2985), However, the transfection plasmid is not integrated into the Plasmodium genome and exists in the form of episomes, which are easily lost, resulting in unstable transfection results, and the induced expression rate of regulated genes is very low (about 20%) and persists. The time is short, and the endogenous gene of Plasmodium remains intact without knockout
However, the Plasmodium whose genes crucial to growth and development are knocked out is difficult to produce in large quantities because the defective strains cannot grow and develop normally. , purification and storage, etc., and once a small number of sporozoites escape the immunity against the liver stage and invade blood red blood cells, they will enter the important stage of malaria parasite pathogenicity, resulting in the failure of vaccine protection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Controllable genome-modified plasmodium, recombinant expression vector and construction method and application of controllable genome-modified plasmodium and recombinant expression vector
  • Controllable genome-modified plasmodium, recombinant expression vector and construction method and application of controllable genome-modified plasmodium and recombinant expression vector
  • Controllable genome-modified plasmodium, recombinant expression vector and construction method and application of controllable genome-modified plasmodium and recombinant expression vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] The controllable genome-modified Plasmodium, recombinant expression vector, construction method and application of the present invention will be further described in detail below in conjunction with the accompanying drawings and specific examples.

[0039] The term "gene expression frame" in the present invention refers to a gene structure consisting of at least a promoter, a coding sequence and a non-coding sequence. The term "functional gene" in the present invention refers to a gene whose translated protein can perform a certain function. The term "target gene" in the present invention refers to the gene expression sequence used for functional research. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as commonly understood by one of ordinary skill in the technical field of the present invention. The terms used in the description of the present invention are only for the purpose of describing specific e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
fluorescenceaaaaaaaaaa
Login to view more

Abstract

The invention relates to a controllable genome-modified plasmodium, a recombinant expression vector and the construction method and application of the controllable genome-modified plasmodium and the recombinant expression vector. The recombinant expression vector comprises a gene targeting long homologous arm, a gene targeting short homologous arm, a tetracycline repression protein gene expression cassette, a pyrimethamine resistance gene expression cassette and a target gene expression cassette, wherein the tetracycline repression protein gene expression cassette, the pyrimethamine resistance gene expression cassette and the target gene expression cassette are located between the gene targeting long homologous arm and the gene targeting short homologous arm, and tetracycline operator gene sequences are inserted in multiple transcriptional start sites of a target gene promoter, so that the recombinant expression vector can be used for conditional research of the functions of a certain functional gene in a plasmodium genome. Furthermore, a functional gene expression sequence, corresponding to a target gene, in the plasmodium genome is knocked out by means of the gene knockout technique; meanwhile, the recombinant expression vector is transfected into a plasmodium with genes knocked out, so that the controllable genome-modified plasmodium is obtained; a new technical scheme is provided for further research of the functions of all functional genes in the plasmodium genome, and application prospects are broad.

Description

technical field [0001] The invention relates to the field of genetic engineering, in particular to a controllable genome-modified malaria parasite, a recombinant expression vector, a construction method, and an application. Background technique [0002] Malaria, caused by Plasmodium infection, is one of the three major infectious diseases worldwide. Malaria infects hundreds of millions of people every year and kills more than a million people, most of them children under the age of five. One of the main reasons why malaria is so difficult to effectively control and eradicate is the limited understanding of the biological complexity of its causative agent, Plasmodium. Plasmodium has a complex life cycle, and its growth and development need to be completed in hosts such as female Anopheles mosquitoes and humans (or other vertebrates): Plasmodium reproduces sexually in Anopheles mosquitoes, and in humans or other vertebrate hosts. reproduce asexually. The development process...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/79C12N15/66C12N1/11A61K39/015A61P33/06C12R1/90
CPCY02A50/30
Inventor 苏钟王琼
Owner GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products